Kamat Hotels turns to ₹5.45 Cr consol. PAT YoY; margins expand, Q2 softens QoQ as guided
revenue +11.45% · margins expanding
₹83.73 Cr
+11.45% YoY
₹5.45 Cr
6.32%
+9.2pp YoY
₹1.59
Kamat Hotels' consolidated profit swung to ₹5.45 Cr for the quarter ended September 2026, against a ₹2.19 Cr loss in the year-ago quarter, as revenue from operations grew 11.5% YoY to ₹83.73 Cr. The year-ago quarter also carried a ₹2.5 Cr exceptional gain that is absent this quarter; stripping that out, the comparable year-ago loss deepens to roughly ₹4.69 Cr, making the swing to this quarter's clean ₹5.45 Cr profit a sharper turnaround than the reported numbers alone suggest. Standalone PAT was ₹7.11 Cr (EPS ₹2.41) against consolidated PAT of ₹5.45 Cr (EPS ₹1.59, after ₹0.77 Cr attributable to non-controlling interests in subsidiaries including Orchid Hotels Pune and Fort Jadhavgadh).
Q2 FY-2027 vs prior quarters
Margins expanded sharply on a YoY basis — operating margin rose to 23.8% from 13.8%, and net margin to 6.3% from -2.9% — but eased from Q1 FY27's 27.2% OPM / 10.4% NPM, with revenue down 7.5% and PAT down 43.8% sequentially. This QoQ softening is consistent with management's own seasonal call on the Q1 FY27 concall that Q1 and Q2 would be soft before an H2 recovery; on that basis the quarter tracks guidance rather than missing it, even though no formal revenue or EBITDA number was ever given. Operating margin at 23.8% also remains roughly 6 points short of management's 2-3 year target of 30% EBITDA margins.
The stock went into the print at ₹233.98, down 1.6% over the past month of trading.
No formal FY27 revenue/EBITDA guidance offered. Management expects Q1, Q2 soft seasonally; H2 recovery. Target 30% EBITDA margins in 2-3 years. ~400 keys expansion planned over 12-15 months (Gwalior, Dwarka, Dehradun, Nashik, Rishikesh, Mandvi).
— This quarter: met
No broker previews or consensus estimates for this specific quarter turned up in a search, consistent with thin formal analyst coverage of the stock; vs-street is accordingly unknown rather than a miss. The quarter's standout corporate action was the board's approval, at the same meeting, of up to ₹168 Cr of investment via OCDs/NCDs into wholly-owned subsidiary Orchid Hotels Pune — funding that ties directly to the ~400-key expansion across Gwalior, Dwarka, Dehradun, Nashik, Rishikesh and Mandvi flagged on the prior call. The board also granted 1,78,000 RSUs under a new FY26 ESOP scheme, a minor item with no P&L impact this quarter. No standalone management press release was available to cross-check against the filing.
W1
H2 FY27 recovery vs the guided seasonal Q1/Q2 softness — FY26 full-year consolidated PAT ran at ₹38.55 Cr, the pace to beat
W2
Deployment of the ₹168 Cr OCD/NCD investment into Orchid Hotels Pune and progress on the ~400-key expansion over the next 12-15 months
W3
OPM trajectory toward management's 2-3 year target of 30% EBITDA margin, from 23.8% this quarter
Converted from ₹ Lakhs; both statements unaudited (limited review only). Year-ago quarter (Q2 FY26) carried a ₹2.50 Cr exceptional gain versus none this quarter, so the adjusted YoY swing is sharper than the reported one. Consolidated PAT of ₹5.4457 Cr includes ₹0.7679 Cr attributable to non-controlling interests (owner's share ₹4.6778 Cr, basic EPS ₹1.59). Arithmetic checks passed on both statements.
Informational and educational content only. Not investment advice.